Release Date: 18/03/15 11:55 Summary: Share Purchase Plan - Offer Document Price Sensitive: No Download Document 535.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%